Market Research Logo

NAL Pharmaceuticals Ltd. - Product Pipeline Review - 2016

NAL Pharmaceuticals Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘NAL Pharmaceuticals Ltd. - Product Pipeline Review - 2016’, provides an overview of the NAL Pharmaceuticals Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by NAL Pharmaceuticals Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of NAL Pharmaceuticals Ltd.
  • The report provides overview of NAL Pharmaceuticals Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses NAL Pharmaceuticals Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features NAL Pharmaceuticals Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate NAL Pharmaceuticals Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for NAL Pharmaceuticals Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding NAL Pharmaceuticals Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


NAL Pharmaceuticals Ltd. Snapshot
NAL Pharmaceuticals Ltd. Overview
Key Information
Key Facts
NAL Pharmaceuticals Ltd. - Research and Development Overview
Key Therapeutic Areas
NAL Pharmaceuticals Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
NAL Pharmaceuticals Ltd. - Pipeline Products Glance
NAL Pharmaceuticals Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
NAL Pharmaceuticals Ltd. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
NAL Pharmaceuticals Ltd. - Drug Profiles
pegfilgrastim
Product Description
Mechanism of Action
R&D Progress
montelukast sodium
Product Description
Mechanism of Action
R&D Progress
diclofenac sodium
Product Description
Mechanism of Action
R&D Progress
donepezil hydrochloride
Product Description
Mechanism of Action
R&D Progress
donepezil hydrochloride Patch
Product Description
Mechanism of Action
R&D Progress
formoterol fumarate
Product Description
Mechanism of Action
R&D Progress
galantamine hydrobromide
Product Description
Mechanism of Action
R&D Progress
indomethacin
Product Description
Mechanism of Action
R&D Progress
ketoprofen
Product Description
Mechanism of Action
R&D Progress
levocetirizine dihydrochloride
Product Description
Mechanism of Action
R&D Progress
NAL-3216
Product Description
Mechanism of Action
R&D Progress
NAL-3221
Product Description
Mechanism of Action
R&D Progress
NAL-3223
Product Description
Mechanism of Action
R&D Progress
nicotine bitartrate
Product Description
Mechanism of Action
R&D Progress
rizatriptan benzoate
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate
Product Description
Mechanism of Action
R&D Progress
sufentanil citrate
Product Description
Mechanism of Action
R&D Progress
tadalafil
Product Description
Mechanism of Action
R&D Progress
tulobuterol
Product Description
Mechanism of Action
R&D Progress
NAL Pharmaceuticals Ltd. - Pipeline Analysis
NAL Pharmaceuticals Ltd. - Pipeline Products by Target
NAL Pharmaceuticals Ltd. - Pipeline Products by Route of Administration
NAL Pharmaceuticals Ltd. - Pipeline Products by Molecule Type
NAL Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action
NAL Pharmaceuticals Ltd. - Dormant Projects
NAL Pharmaceuticals Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
NAL Pharmaceuticals Ltd., Key Information
NAL Pharmaceuticals Ltd., Key Facts
NAL Pharmaceuticals Ltd. - Pipeline by Indication, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016
NAL Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016
NAL Pharmaceuticals Ltd. - Preclinical, 2016
NAL Pharmaceuticals Ltd. - Discovery, 2016
NAL Pharmaceuticals Ltd. - Unknown, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Target, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016
NAL Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2016
NAL Pharmaceuticals Ltd. - Dormant Developmental Projects,2016
List of Figures
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016
NAL Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Target, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Route of Administration, 2016
NAL Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016
NAL Pharmaceuticals Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report